SEARCH   
MEMBER LOGIN    
Top 500

Veterinary Pharmaceutical Manufacturing in Australia: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Veterinary Pharmaceutical Manufacturing Market Research Report | ANZSIC C1842 | Feb 2016

Top dog: Pet humanisation trends are driving sales of pharmaceuticals for companion animals

IBISWorld’s Veterinary Pharmaceutical Manufacturing market research report is a comprehensive guide to market size and growth prospects. Our industry reports offer strategic industry analysis of the factors influencing companies, including new product developments, economic, lifestyle and demographic influences, distribution and supply chain factors and pricing issues. Full analysis accompanies our data forecasts to illustrate how the market responds to emerging industry trends.

Report Snapshot
Industry Statistics & Market Size
Revenue
$525m
Annual Growth 11-16
5.6%
Annual Growth 16-21
Add to Cart
Profit
Add to Cart
Employment
1,140
Businesses
57
Industry Analysis & Industry Trends

The Veterinary Pharmaceutical Manufacturing industry is a small segment of the general Australian pharmaceutical sector. The industry develops and manufactures animal health products, including veterinary medicines, vaccines, and other biological and medicinal feed additives. As such, it is geared towards two main segments: food-producing animals (including cattle, pigs, poultry and sheep) and companion animals (including cats and dogs). The industry accounts for just over 5% of the pharmaceutical sector.

Over the five years through 2015-16, the industry has had a highly volatile performance due to various external shocks... purchase to read more

Industry Report - Industry Key Buyers Chapter

Echoing the unprecedented degree of change currently occurring within the general pharmaceutical sector, the competitive landscape of the Veterinary Pharmaceutical Manufacturing industry has undergone significant change in the five years through 2015-16. Consolidation pressures continue to characterise the industry, and this has had implications for market share concentration trends. Following Pfizer's 2009 acquisition of Wyeth Corporation and its subsidiary Fort Dodge Animal Health, the industry underwent a significant shake up. Fort Dodge's assets were split in Australia between Pfizer and Virbac, both already major players. This resulted in increased industry concentration... purchase to read more

 


Industry ProductsRelated ReportsTable of Contents

What is the Veterinary Pharmaceutical Manufacturing Industry?

This industry manufactures drugs, medicines, medicinal chemicals, vaccines, serums and other pharmaceutical products for veterinary use. These animal health products are targeted towards food-producing animals (cattle, pigs, poultry and sheep) and companion animals (dogs and cats).

Industry Products
ParasiticidesOther productsAntibiotics and related productsImmunotherapy products and vaccinesNutrition and metabolism productsDermatological preparationsMusculosketal system products
 
Industry Activities
ParasiticidesImmunotherapy product including vaccinesNutritional and metabolism productAntibioticsOther animal healthcare product


View Sample
Quote
Select Clients